Pharma Pulse 9/16/24: Overcoming the Challenges of PBMs, Hopeful News for Users of ADHD Drug & more

A New Regulatory Road in Clinical Trials: Digital Twins

The promise and acceptance of using this AI tool in drug development is growing.

Overcoming the Challenges of PBMs: Expanding Patient Access to Affordable Treatments

In an interview with Pharmacy Times® at the Community Oncology Alliance (COA) 2024 Payer Exchange, Fred Barton, PharmD, and vice president of clinical product and partnerships at AffirmedRx, explains the challenges of PBMs in the health care industry and the steps that need to be taken to promote more transparency.

Hopeful News for Users of One A.D.H.D. Drug

The D.E.A. is increasing its quota for Vyvanse as patients still struggle to fill prescriptions.

Advanced eClinical Training Partners with The Education Fund to Expand Educational Opportunities for Healthcare Workers

This collaboration provides union healthcare workers with access to high-demand Allied Health certifications through short-term online and blended programs.

UpScriptHealth on LinkedIn

Our Founder & CEO, Peter Ax, and Chief Operating Officer, George Jones, recently shared their insights with Miranda Schmalfuhs at Pharmaceutical Executive about the current weight loss drug marketplace.

#Telemedicine #WeightLossDrugs

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs